Asthma Treatments: Inhalations
ASTHMA TREATMENTS: INHALATIONS | ||||
---|---|---|---|---|
Generic | Brand | Strength | Form | Dosage |
ANTICHOLINERGIC | ||||
tiotropium bromide monohydrate | Spiriva Respimat | 1.25mcg, 2.5mcg | soln | Children: Not established.
Adults: 2 inh of 1.25mcg/actuation (2.5mcg) once daily. |
BETA2-AGONIST | ||||
albuterol sulfate | — | 0.5% | soln | Children: Use other forms.
Adults: Use nebulizer. 2.5mg 3−4 times daily. |
0.083% | soln | <4yrs: Not recommended.
≥4yrs: Bronchospasm: 2 inh every 4−6hrs as needed; 1 inh every 4hrs may suffice. EIB: 2 inh 15min before exercise. |
||
90mcg | MDI | |||
ProAir Digihaler | 90mcg | DPI | <4yrs: Not established.
≥4yrs: Bronchospasm: 2 inh every 4−6hrs as needed; 1 inh every 4hrs may suffice. EIB: 2 inh 15−30min before exercise. |
|
ProAir HFA | 90mcg | MDA | ||
ProAir RespiClick | 90mcg | DPI | ||
Proventil HFA | 90mcg | MDA | ||
Ventolin HFA | 90mcg | MDA | ||
levalbuterol HCl | Xopenex | 0.31mg/ 3mL, 0.63mg/ 3mL, 1.25mg/ 3mL |
soln | <6yrs: Not established.
6−11yrs: 0.31mg by nebulization 3 times daily; max 0.63mg 3 times daily. ≥12yrs: Initially 0.63mg 3 times daily at 6−8hrs intervals; may increase to 1.25mg 3 times daily. |
Xopenex Concen– trate |
1.25mg/ 0.5mL |
soln | ||
levalbuterol tartrate | Xopenex HFA | 45mcg | MDI | <4yrs: Not established.
≥4yrs: 2 inh every 4−6hrs; 1 inh every 4hrs may suffice. |
LONG-ACTING BETA2‑AGONIST | ||||
salmeterol xinafoate | Serevent Diskus | 50mcg | DPI | <4yrs: Not established. ≥4yrs: Asthma: 1 inh twice daily (approx. 12hrs apart) with concomitant ICS. EIB: 1 inh ≥30mins before exercise; do not use additional doses for 12hrs after administration or if already using twice daily dosing. Max 1 inh twice daily. |
MAST CELL STABILIZER | ||||
cromolyn sodium | — | 20mg/ 2mL |
soln | <2yrs: Not recommended.
≥2yrs: Use nebulizer. 20mg 4 times a day. |
STEROID | ||||
beclometh– asone dipropri– onate |
Qvar Redihaler | 40mcg, 80mcg | MDI | <4yrs: Not established.
4−11yrs: Initially 40mcg twice daily (approx. 12hrs apart); max 80mcg twice daily. ≥12yrs: Previously not on inhaled corticosteroids: Initially 40–80mcg twice daily (approx. 12hrs apart). Previously on inhaled corticosteroids: Initially 40–320mcg twice daily. Both: Max 320mcg twice daily. |
budesonide | Pulmicort Flexhaler | 90mcg, 180mcg |
DPI | <6yrs: Not recommended.
6−17yrs: Initially 180mcg twice daily; may start at 360mcg twice daily; max 360mcg twice daily. ≥18yrs: Initially 360mcg twice daily; 180mcg twice daily may suffice; max 720mcg twice daily. |
Pulmicort Respules | 0.25mg/ 2mL, 0.5mg/ 2mL, 1mg/ 2mL |
susp | <6mos: Not recommended.
6−12mos: Not established. 12mos−8yrs: Previously on bronchodilators alone: 0.5mg once daily or 0.25mg twice daily. Previously on inhaled corticosteroids: 0.5mg once daily or 0.25mg twice daily; max 1mg/day. Previously on oral corticosteroids: 0.5mg twice daily or 1mg once daily. |
|
ciclesonide | Alvesco | 80mcg,
160mcg |
MDA | <12yrs: Not recommended.
≥12yrs: Previously on bronchodilators alone: Initially 80mcg twice daily, max 160mcg twice daily. Previously on inhaled corticosteroids: Initially 80mcg twice daily; max 320mcg twice daily. Previously on oral corticosteroids (see full labeling): 320mcg twice daily. |
fluticasone furoate | Arnuity Ellipta | 50mcg, 100mcg,
200mcg |
DPI | <5yrs: Not established. 5–11yrs: 50mcg once daily. ≥12yrs: Base initial dose on previous asthma therapy and disease severity. Not on inhaled corticosteroid: usually initiate at 100mcg once daily; may increase to 200mcg once daily if inadequate response after 2 weeks. Max 200mcg/day. |
fluticasone propionate | ArmonAir Digihaler | 55mcg, 113mcg, 232mcg | DPI | <4yrs: Not established. 4–11yrs: Not previously on ICS: initially 1 inh of 30mcg twice daily. Switching from another ICS: 1 inh of 30mcg or 55mcg twice daily, based on disease severity and previous ICS therapy. ≥12yrs: Give doses approx. 12hrs apart. Not previously on ICS: initially 1 inh of 55mcg twice daily. For greater severity: either 113mcg or 232mcg given twice daily. Switching from another ICS: 1 inh of 55mcg, 113mcg, or 232mcg twice daily, based on disease severity and previous ICS therapy. If insufficient response after 2wks, increase dose. Max 1 inh of 232mcg twice daily. |
Flovent Diskus | 50mcg,
100mcg, 250mcg |
DPI | <4yrs: Not recommended.
4−11yrs: Previously on bronchodilators alone or on inhaled corticosteroids: Initially 50mcg twice daily; max 100mcg twice daily. ≥11yrs: Previously on bronchodilators alone: Initially 100mcg twice daily; max 500mcg twice daily. Previously on inhaled corticosteroids: Initially 100−250mcg twice daily; max 500mcg twice daily. Previously on oral corticosteroids (wean gradually): Initially 500−1000mcg twice daily; max 1000mcg twice daily. |
|
Flovent HFA | 44mcg,
110mcg, 220mcg |
MDI | <4yrs: Not established.
4−11yrs: max 88mcg twice daily. ≥12yrs: Previously on bronchodilators alone: Initially 88mcg twice daily; max 440mcg twice daily. Previously on inhaled steroids: Initially 88−220mcg twice daily; max 440mcg twice daily. Previously on oral steroids: Initially 440mcg twice daily; max 880mcg twice daily. |
|
momet– asone furoate |
Asmanex HFA | 50mcg, 100mcg, 200mcg |
MDI | <5yrs: Not established. 5–11yrs: 2 inh of 50mcg twice daily (AM & PM); max 200mcg/day. ≥12yrs: Currently not on inhaled corticosteroids: initially 2 inh of 100mcg twice daily (AM & PM). Currently on chronic oral corticosteroid: initially 2 inh of 200mcg twice daily (AM & PM). If inadequate response after 2wks, may increase dose for additional control. Max: 800mcg/day. |
Asmanex Twisthaler | 110mcg,
220mcg |
DPI | <4yrs: Not established.
4−11yrs: 110mcg once in PM; max 110mcg/day. ≥12yrs: Previously on bronchodilators alone or inhaled steroids: Initially 220mcg once in PM; max 440mcg/day (as 2 inh once daily or 1 inh twice daily). Previously on oral steroids: Initially 440mcg twice daily; max 880mcg/day. |
|
STEROID + LONG-ACTING BETA2‑AGONIST | ||||
budesonide/
formoterol fumarate dihydrate |
Symbicort | 80mcg/4.5mcg,
160mcg/4.5mcg |
MDI | <6yrs: Not established. 6–<12yrs: 2 inh of 80/4.5 twice daily (AM & PM). ≥12yrs: Base initial dose on asthma severity. 2 inh of 80/4.5 or 160/4.5 twice daily (AM & PM). If insufficient response after 1–2wks of 80/4.5 strength, may switch to 160/4.5 strength. Max 2 inh of 160/4.5 twice daily. |
fluticasone furoate/ vilanterol |
Breo Ellipta | 100mcg/25mcg,
200mcg/25mcg |
DPI | Children: ≤17yrs: Not established.
Adults: Initially 1 inh of 100/25mcg or 200/25mcg once daily, based on disease severity and previous asthma therapy. Max 1 inh of 200/25mcg once daily. |
fluticasone propionate/ salmeterol |
Advair Diskus | 100mcg/50mcg,
250mcg/50mcg, 500mcg/50mcg |
DPI | <4yrs: Not established.
4−11yrs: 1 inh of 100/50 twice daily ≥12yrs: Initially 1 inh of 100/50, 250/50 or 500/50 twice daily, based on disease severity and previous asthma therapy; if insufficient response after 2wks, use next higher strength. Max 1 inh of 500/50 twice daily. |
Advair HFA | 45mcg/21mcg,
115mcg/21mcg, 230mcg/21mcg |
MDI | <12yrs: Not established.
≥12yrs:Initially 2 inh of 45/21, 115/21 or 230/21 twice daily, based on disease severity and previous asthma therapy; if insufficient response after 2wks, use next higher strength. Max 2 inh of 230/21 twice daily. |
|
AirDuo Digihaler | 55mcg/14mcg, 113mcg/14mcg, 232mcg/14mcg | DPI | <12yrs: Not established.
≥12yrs: Give doses approx. 12hrs apart. Not previously on ICS: initially 1 inh of 55/14mcg twice daily. Switching from an ICS or combination product: 1 inh of 55/14mcg, 113/14mcg or 232/14mcg twice daily, based on disease severity and previous asthma therapy. If insufficient response after 2wks, use next higher strength. Max 1 inh of 232/14mcg twice daily. |
|
AirDuo RespiClick | ||||
Wixela Inhub | 100mcg/50mcg, 250mcg/50mcg, 500mcg/50mcg |
DPI | <4yrs: Not established. 4–11yrs: 1 inh of 100/50 twice daily (approx. 12hrs apart). ≥12yrs: Initially 1 inh of 100/50 or 250/50 or 500/50 twice daily (approx. 12hrs apart), based on disease severity and previous asthma therapy. If insufficient response after 2wks, use next higher strength. Max 1 inh of 500/50 twice daily. |
|
momet– asone furoate/ formoterol fumarate dihydrate |
Dulera | 50mcg/5mcg, 100mcg/5mcg, 200mcg/5mcg |
MDI | <5yrs: Not established. 5–11yrs: 2 inh of 50mcg/5mcg twice daily (AM & PM); max 200mcg/20mcg daily. ≥12yrs: Initially 2 inh of 100mcg/5mcg or 200mcg/5mcg twice daily (AM & PM), based on disease severity and previous asthma therapy. Max 2 inh of 200mcg/5mcg twice daily (max 800mcg/20mcg per day). |
STEROID + ANTICHOLINERIC +LONG-ACTING BETA2‑AGONIST | ||||
fluticasone + umeclidinium + vilanterol | Trelegy Ellipta | 100/62.5/ 25mcg, 200/62.5/ 25mcg |
DPI | Adults: initially 1 inh of 100/62.5/25mcg or 200/62.5/25mcg once daily, based on disease severity and previous asthma therapy. Max 1 inh of 200/62.5/25mcg once daily. Children: ≤17yrs: Not established. |
NOTES | ||||
Key: DPI = dry powder for inhalation, EIB = exercise induced bronchospasm, MDI = metered-dose inhale, MDA = metered dose aerosol, soln = solution for inhalation, susp = suspension for inhalation (Rev. 10/2022) |